Financial

Yesterday’s Consideration Stock: Myriad Genetics, Inc. (NASDAQ:MYGN)

0 6

Myriad Genetics, Inc. (NASDAQ:MYGN) ended its last trade at $22.31 with the move of +1.87%. The company has market value of $1.54B with the total traded volume of 1.86 million. The stock currently has its 52-Week top value of $46.24 and 52-week down value of $19.10. The price to book (P/B) ratio of the company is 2.02. Its previous closing price was recorded at $21.90.

Currently Myriad Genetics, Inc. (MYGN) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “5″ Analysts”. “3” rated “Sell” for the company. “8” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “1”.

Analysts are expecting that the company to achieve $23.83 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $42.00 however minimum price target advised by analysts is $18.00. The Median price target for the stock is measured at $21.50.

Presently, Analysts decided consensus EPS estimate of $0.26 for present quarter and one month ago projected EPS estimate was at $0.27. If we take a look at back 3 month ago, consensus EPS estimate was $0.42.

A current consensus EPS estimate for next quarter is at $0.28 and 3 month ago EPS forecast was $0.46. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.29.

For current fiscal year, most recent EPS estimate is set at $1.06 based on Analyst consensus and three month ago consensus EPS opinions was at $1.78. During period one month ago, consensus EPS forecast was decided at $1.06.

A current consensus EPS projection for next fiscal year is observed at $1.24 and one month ago consensus EPS forecast was at $1.26. Take a look at back three month ago, consensus EPS estimate opinions was decided at $1.89 by analysts.

One Month ago, the stock has gained consensus mean rating of Hold based on the analysis of brokerage analyst firms polled. 4 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 10 advised the “Hold” rating about this stock. 3 revealed “Sell” signal and “Underweight” rating was declared by 1.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 8 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 3 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter